United Laboratories International (ULIHF) to Post Quarterly Earnings on Monday

United Laboratories International (OTCMKTS:ULIHF) will likely be releasing its results after the market closes on Monday, August 31st. Analysts expect United Laboratories International to post earnings of $0.0191 per share and revenue of $818.7220 million for the quarter.

United Laboratories International Price Performance

Shares of OTCMKTS:ULIHF opened at $1.14 on Friday. The firm has a fifty day moving average of $1.23 and a two-hundred day moving average of $1.36. United Laboratories International has a 12-month low of $1.14 and a 12-month high of $1.70.

About United Laboratories International

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.